What Is CENTOGENE?
CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients. With headquarters in Rostock, Germany and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families.
CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.
We are committed to ‘un-rare’ rare diseases by using our worldwide knowledge in the rare disease market, understanding the epidemiology, analyzing clinical heterogeneity of the more than 3800 diseases and developing innovative biomarkers. Based on this knowledge we are bringing rationality to treatment decisions and, thereby, accelerate the development of new orphan drugs.
CENTOGENE was founded in 2006 on the vision of the Company’s founder Dr. Arndt Rolfs, a Neurologist with vast clinical experience in rare hereditary diseases: transform the science of clinical and genetic data into medical solutions for patients with orphan diseases.
This vision is based on the fact that among the 7,000 identified rare diseases, it is estimated that 80% – or 5,600 – have a genetic origin. Of these hereditary rare diseases, roughly only 4 % have an FDA approved treatment.
As it normally takes an average of around seven years for a patient with a rare disease to be diagnosed, there is a significant unmet global need for high-quality genetic information in the rare disease space for the early identification, effective treatment of patients, and the acceleration of orphan drug development.
CENTOGENE’s data repository, which we believe the world’s largest repository for genetic information on rare hereditary diseases in the world, is the foundation of CENTOGENE’s pursuit of Dr. Rolfs’ vision. The data repository combines worldwide clinical and epidemiological data, and detailed access to phenotype, genotype, proteomics, and metabolomics data to aid in the development of new treatments.
CENTOGENE is guided on the belief that a detailed, global understanding of the genetic basis and the clinical phenotype of rare hereditary diseases will unlock the ability to target rare diseases, and provide critical knowledge that will guide and facilitate every stage of ophan drug development.
Dedicated to Improving the Lives of Patients Every Day
We are dedicated to transforming the science of genetic information into solutions and hope for patients and their families.
CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for patients in international biotechnology and knowledge-generating company with a global network.
Where to find us
CENTOGENE is one of the world's leading companies in the field of rare genetic disease diagnostics.
With our broad international network of experienced employees, we are able to offer a wide range of services and support in diverse local languages worldwide.
In collaboration with our partners, we continually develop and test new diagnostic techniques, and are therefore always able to offer you the latest and most effective solutions to your diagnostic challenges.
Our business locations
Am Strande 7
Hamburg Business Location
USA Business Location
CENTOGENE US, LLC
99 Erie Street
Cambridge, MA 02139
UAE Business Location
Executive Office AC04, 2nd Floor
Building 2, Dubai Media City
Berlin Business Location
Frankfurt Business Location
Gebäude G830, 1.OG,
Switzerland Business Location
CENTOGENE Switzerland AG
India Business Location
CENTOGENE India Private Limited
107 Wegman's Business Park, Knowledge Park III
Surajpur-Kasna Road, Greater NOIDA - 201308